Primary Job Title Board of Advisors Primary Organization 
Sensoria
Location United States, North America Gender Male
Gordon has a distinguished 40-year career with major U.S. pharmaceutical companies and a principal international non-profit research and development institution. He has conducted fundamental research and managed multidisciplinary, multinational research and development programs, including a 2,000-member, three-continent research and development
program. Gordon oversaw the discovery, development and launch of medically unique drugs and devices, designed and managed clinical trials and regulatory applications, and consulted for programs with government, academic and industrial institutions. Gordon spent 20 years with the Upjohn Company as a Vice President and Executive Director.
His duties included major roles in Upjohn’s drug discovery, drug development and clinical development efforts. He has more recently been a member of senior management for four emerging biopharmaceutical companies including ProCyte Corp., BioFrontiers, Inc., AVI BioPharma, and Women’s Capital Corp., where he successfully developed and launched Plan B, a significant product for women’s health care. Gordon was also the first Executive Director of PATH, an influential non-profit organization. He earned his B.S. at Cornell University and his M.S. and Ph.D. at Iowa State University.
